Foundation Venture Capital Group, LLC was formed as a scientific discovery private equity venture fund.

The corporation collaborates with the Office of Patents and Licensing at the University of Medicine and Dentistry of New Jersey to provide support and opportunities for University researchers by using private equity investments to make early stage investments in life science companies that license UMDNJ technology.

The faculty at UMDNJ has been involved in breakthrough research projects for years, many of them ready to successfully be brought to market. These projects present opportunities to make early private equity investments in diverse areas.

This extra early funding means that emerging medical breakthroughs in research and technology businesses can be sustained by sufficient venture capital to optimize their chances of success and ultimately to provide revenue to UMDNJ and the group that support these ventures. This funding fills a void by promoting the establishment of companies that would most likely not be formed otherwise.

Once these companies are established with this seed funding, Foundation Venture Capital Group, LLC, will seek to work with other traditional venture capital companies to partner in the effort to advance these technologies.

This forward-thinking concept can prove transformational for the mission of the Foundation of UMDNJ, for researchers at the University by funding projects that might not ordinarily receive funding any other way, for patients who can take advantage of the newest products to be developed and for investors in the fund.